#United States #Miami #Healthcare Conference #Quest Diagnostics #Sam Samad

Quest Diagnostics Will Present at the Leerink 2026 Global Healthcare Conference

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the realm of diagnostic information services, has announced an important speaking engagement at the upcoming Leerink 2026 Global Healthcare Conference. Scheduled for March 11, 2026, in Miami, the conference will feature Sam Samad, the company’s Executive Vice President and Chief Financial Officer. During this event, Samad will share insights into the company’s strategic vision, performance, and key trends shaping the healthcare market today.

This interface not only allows Quest Diagnostics to outline its operational trajectory but also to engage with both investors and industry stakeholders about the ongoing developments in the healthcare sector. The Fireside Chat, which will be a focal point during the conference, will also include a Q&A session where attendees will get the opportunity to interact and pose questions directly to Mr. Samad.

In addition to live participation, the conference will feature a webcast that can be accessed via the Quest Diagnostics investor relations website at ir.QuestDiagnostics.com. This ensures that those who are unable to attend the event in person can still gain valuable insights. Following the conclusion of the live session, the archived version of the webcast is expected to be available within 24 hours, providing extended access until March 25, 2026.

Quest Diagnostics has long been dedicated to enhancing the healthcare landscape, striving to make medical testing more accessible and informative for both clinicians and patients alike. Across the U.S., Quest Diagnostics operates within a vast network, serving nearly half of the physicians and hospitals, with about one-third of American adults relying on their services each year. Their commitment is fundamentally about delivering high-quality diagnostic insights that empower better healthcare decisions and outcomes.

Through the integration of advanced technology and continuous innovation, Quest Diagnostics aims to create a healthier world by illuminating pathways to better health. Their dedication to improving testing practices and providing clearer diagnostic information speaks directly to their mission of transforming lives through reliable healthcare solutions.

As the healthcare industry continues to navigate complex challenges and transformations, conferences like Leerink 2026 become crucial platforms for sharing knowledge and fostering collaboration. Quest Diagnostics looks forward to contributing to this discourse and to furthering its commitment to enhancing patient care.

For anyone keen on understanding the trajectory of Quest Diagnostics and its vision for the future of healthcare, tuning into this conference will undoubtedly offer valuable perspectives and insights. Don’t miss the chance to witness a detailed overview of what’s next for this leader in diagnostic services, as it sets the stage for continued innovation in healthcare delivery.

About Quest Diagnostics

Quest Diagnostics operates with the goal of bridging the gap in healthcare by connecting individuals, from consumers to healthcare providers, with crucial laboratory insights. This connectivity plays a pivotal role in identifying and managing health issues, encouraging preventive behaviors, and overall improving healthcare management. With a team of nearly 57,000 dedicated employees, Quest Diagnostics remains steadfast in its mission to serve millions within the healthcare ecosystem, constantly innovating to ensure that every test reveals new opportunities for detecting and treating diseases effectively.

The conference promises to be a significant step forward in showcasing how Quest Diagnostics is adapting and thriving in the ever-evolving health landscape. Mark your calendars for March 11, 2026, and be part of this informative session.